全文获取类型
收费全文 | 277213篇 |
免费 | 17785篇 |
国内免费 | 1856篇 |
专业分类
耳鼻咽喉 | 3340篇 |
儿科学 | 5745篇 |
妇产科学 | 4614篇 |
基础医学 | 40538篇 |
口腔科学 | 6455篇 |
临床医学 | 26302篇 |
内科学 | 55114篇 |
皮肤病学 | 6804篇 |
神经病学 | 24947篇 |
特种医学 | 13316篇 |
外国民族医学 | 6篇 |
外科学 | 39309篇 |
综合类 | 2421篇 |
现状与发展 | 5篇 |
一般理论 | 165篇 |
预防医学 | 17591篇 |
眼科学 | 6324篇 |
药学 | 21775篇 |
2篇 | |
中国医学 | 1699篇 |
肿瘤学 | 20382篇 |
出版年
2023年 | 1710篇 |
2022年 | 3934篇 |
2021年 | 7141篇 |
2020年 | 4014篇 |
2019年 | 5711篇 |
2018年 | 7041篇 |
2017年 | 5596篇 |
2016年 | 6884篇 |
2015年 | 8894篇 |
2014年 | 11380篇 |
2013年 | 14190篇 |
2012年 | 21540篇 |
2011年 | 21718篇 |
2010年 | 12412篇 |
2009年 | 11252篇 |
2008年 | 17582篇 |
2007年 | 17884篇 |
2006年 | 16684篇 |
2005年 | 16445篇 |
2004年 | 15090篇 |
2003年 | 13896篇 |
2002年 | 12707篇 |
2001年 | 4504篇 |
2000年 | 3892篇 |
1999年 | 3717篇 |
1998年 | 2986篇 |
1997年 | 2296篇 |
1996年 | 1921篇 |
1995年 | 1737篇 |
1994年 | 1525篇 |
1993年 | 1437篇 |
1992年 | 1515篇 |
1991年 | 1474篇 |
1990年 | 1247篇 |
1989年 | 1148篇 |
1988年 | 1020篇 |
1987年 | 1036篇 |
1986年 | 837篇 |
1985年 | 900篇 |
1984年 | 894篇 |
1983年 | 756篇 |
1982年 | 887篇 |
1981年 | 863篇 |
1980年 | 728篇 |
1979年 | 586篇 |
1978年 | 537篇 |
1977年 | 519篇 |
1976年 | 474篇 |
1975年 | 413篇 |
1974年 | 388篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
101.
102.
Interaction effects between the 5‐hydroxy tryptamine transporter‐linked polymorphic region (5‐HTTLPR) genotype and family conflict on adolescent alcohol use and misuse
下载免费PDF全文
![点击此处可从《Addiction (Abingdon, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
103.
104.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献105.
Thaís dos Santos Fontes Pereira Carolina Cavalieri Gomes Peter A Brennan Felipe Paiva Fonseca Ricardo Santiago Gomez 《Journal of oral pathology & medicine》2019,48(1):3-9
Fibrous dysplasia is a non‐neoplastic developmental process that affects the craniofacial bones, characterized by painless enlargement as a result of bone substitution by abnormal fibrous tissue. Postzygotic somatic activating mutations in the GNAS1 gene cause fibrous dysplasia and have been extensively investigated, as well as being helpful in the differential diagnosis of the disease. Fibrous dysplasia may involve one (monostotic) or multiple bones (polyostotic), sporadically or in association with McCune‐Albright syndrome, Jeffe‐Lichenstein syndrome, or Mazabreud syndrome. This review summarizes the current knowledge on fibrous dysplasia, emphasizing the value of integrating the understanding of its molecular pathogenesis with the clinical, radiological, and histopathological features. In addition, we address important aspects related to the differential diagnosis and patient management. 相似文献
106.
107.
108.
Auda A. Eltahla Fabio Luciani Peter A. White Andrew R. Lloyd Rowena A. Bull 《Viruses》2015,7(10):5206-5224
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens. 相似文献
109.
110.